Drug intelligence / Profile preview

3,20-pregnanedione

Development stage: Unknown
Modality: Small Molecules

Overview

**3,20-Pregnanedione** is a synthetic or naturally occurring steroid belonging to the class of gluco/mineralocorticoids and progestogens. It is a C21-steroid with oxo groups at positions 3 and 20 on the pregnane backbone. This compound exists as both a human and mouse metabolite and is structurally related to progesterone metabolites. While it has been studied as an experimental small molecule in research settings—particularly for its role in steroid metabolism—there are no approved therapeutic indications or clinical uses reported for this compound[1][2]. Its mechanism of action as a drug has not been established; however, related compounds can modulate neurosteroid activity.

Other names: 5beta-pregnane-3,20-dione5β-pregnane-3,20-dionePregnane-3,20-dione, (5beta)-(5alpha,8alpha,10alpha,14beta,17alpha)-pregnane-3,20-dione

Beyond the preview

Go deeper on 3,20-pregnanedione.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3,20-pregnanedione.

Explore the full profile